ACCC | FDA Approves Drug for Thrombocytopenia in Adults with Chronic Liver Disease
FDA Approves Drug for Thrombocytopenia in Adults with Chronic Liver Disease
On May 21, 2018, the Food and Drug Administration approved avatrombopag (Doptelet, AkaRx Inc.) for thrombocytopenia in adults with chronic liver disease scheduled to undergo a procedure.
In Person Conference & ConventionSeptember 22, 2026 at 5:00 PM CDT1500 Park Pl Blvd, Minneapolis, MN, USADoubleTree by Hilton Hotel Minneapolis - Park Place, Minneapolis
In Person Conference & ConventionOctober 3, 2026 at 7:30 AM EDT8787 Keystone Crossing, Indianapolis, IN, USASheraton Indianapolis Hotel at Keystone Crossing, Indianapolis
